We are pleased to present below all posts archived in 'March, 2014'. If you still can't find what you are looking for, try using the search box.
27th March, 2014 – The SysQuant® study addressing pancreatic cancer published yesterday in PLOS ONE provides a helicopter view over cell signalling pathways that elegantly demonstrates Proteome Sciences ability to measure the phosphorylation status and expression of very important drug targets and many other signalling proteins. This technology is equally applicable to all cancers.
Read the rest of entry »
Please find below industry commentary from Siemens Healthcare responding to the report from the all-party Parliamentary Hepatology Group outlining how deaths from liver disease in England have risen by 40% between 2001-2012.
Cardiff, UK – 25th March 2014 – EKF Diagnostics (www.ekfdiagnostics.com), the global in vitro diagnostics business, will be present on Booth #438 at AACR 2014 (American Association of Cancer Research), 5-9th April, San Diego. EKF Molecular will exhibit its PointMan™ DNA-enrichment technology which enables ultra-sensitive and highly-specific cancer mutation detection unmatched by existing technologies.
Siemens Healthcare Diagnostics recently held a BN™II and BN ProSpec® Customer Connection Event in Birmingham, providing delegates with updates on the latest developments and tools available. The two-day event attracted customers using the plasma protein systems from all across the UK and provided an opportunity to interact with colleagues and Siemens experts to share experience and best practice.
Who are the BIVDA Members
Member Press Releases
Point of Care Directory
News, Policy and Media
BIVDA Press Releases